trial · primary record
Antigen-specific T cells CAR-T/CTL and DCvac
T-Cell Acute Lymphoblastic Leukemia
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Treatment-related adverse events are assessed by NCI CTCAE V4.0 criteria. |
| Registry ID | NCT05277753 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.387Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05277753
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.